NCT03725839View on ClinicalTrials.gov

The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Sleep Disordered BreathingObstructive Sleep Apnea
Interventions
DEVICE

F&P Interface

F\&P Interface to be used for OSA therapy

Trial Locations (3)

2013

Fisher & Paykel Healthcare, Auckland

4120

Hawkes Bay Fallen Soldiers' Memorial Hospital, Hastings

6035

Well Sleep, Wellington

All Listed Sponsors
lead

Fisher and Paykel Healthcare

INDUSTRY

NCT03725839 - The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA) | Biotech Hunter | Biotech Hunter